HopeStage
Study directory

Schizophrenia studies

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

Back to overview
More filters: keywords, city, remote
453studies shown
Showing 397-408 of 453
Drug study icon
RecruitingNCT05025605

BXCL501 for schizophrenia

Official study title

A Randomized, Double-blind, Placebo-controlled Study to Determine Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder

Multiple locations, including Anaheim
Bipolarity, SchizophreniaMedication studyAges 10–17
Countries
United States
Sponsor
BioXcel Therapeutics Inc
Biological study icon
RecruitingNCT05480826

Genetic Variants Identified for treatment-resistant depression

Official study title

Familial and Functional Study of Genetic Variants Identified in People With Schizophrenia, Bipolar Disorder, Autism Spectrum Disorder or Resistant Depression

In Créteil
Bipolarity, Depression, ...Interventional studyAges 18+
Countries
France
Sponsor
Fondation FondaMental
Drug study icon
RecruitingNCT05603104

Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Depression in bipolarity After a First-time Treatment Failure

Official study title

A Randomised, Controlled Trial to Investigate the Effect of an Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.

In Ramat Gan
Depression, Bipolarity, ...Medication studyAges 18–70
Countries
Israel
Sponsor
Dr. Inge Winter
Drug study icon
RecruitingNCT06229210

Safety and Tolerability study of Lumateperone in Pediatric people with Schizophrenia, Bipolarity or Autism Spectrum Disorder

Official study title

An Open-label, Multicenter Trial to Assess the Safety and Tolerability of Lumateperone in the Treatment of Pediatric Patients With Schizophrenia, Bipolar Disorder, or Autism Spectrum Disorder

Multiple locations, including Phoenix
Bipolarity, SchizophreniaMedication studyAges 5–17
Countries
United States, Colombia, Serbia
Sponsor
Intra-Cellular Therapies, Inc.
Drug study icon
RecruitingNCT05303064

Weight Gain for schizophrenia

Official study title

A Phase 3, Randomized, Double-Blind, 52-Week Study of OLZ/SAM vs Olanzapine to Evaluate Weight Gain as Assessed by Change in BMI Z-Score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder (ENLIGHTEN-Youth)

Multiple locations, including Dothan
Bipolarity, SchizophreniaMedication studyAges 10–17
Countries
United States, Argentina, Brazil, + 2 others
Sponsor
Alkermes, Inc.
Behavioral study icon
RecruitingNCT04432116

Time and Virtual Reality in Schizophrenia and Bipolarity

Official study title

EEG and Behavioural Correlates of Virtual Reality Treatment of Environmental Zeitgebers in Schizophrenia and Bipolar Disorder

In Strasbourg
Bipolarity, SchizophreniaBehavioural studyAges 18–60
Countries
France
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.